share_log

信邦制药(002390.SZ):下属医院近期上呼吸道感染就诊人数有所增加

Xinbang Pharmaceutical (002390.SZ): The number of patients treated for upper respiratory infections in affiliated hospitals has increased recently

Gelonghui Finance ·  Dec 5, 2023 02:54

Gelonghui, December 5, Xinbang Pharmaceutical (002390.SZ) said on an interactive platform that due to seasonal factors, the number of patients treated for upper respiratory infections in the company's hospitals has recently increased.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment